The cellular protein lyric interacts with HIV-1 gag

Journal of Virology

Volumn 85, Issue 24, 2011, Pages 13322-13332

  Engeland, Christine E ^a   Oberwinkler, Heike ^a   Schümann, Michael ^b   Krause, Eberhard ^b   Müller, Gerd A ^c   Kräusslich, Hans Georg ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE; LYRIC PROTEIN; MATRIX PROTEIN; NUCLEOCAPSID PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; EQUINE INFECTIOUS ANEMIA VIRUS; IMMUNOPRECIPITATION; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; UPREGULATION; VIRION; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS PARTICLE;

CELL ADHESION MOLECULES; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; INFECTIOUS ANEMIA VIRUS, EQUINE; LEUKEMIA VIRUS, MURINE; PROTEIN BINDING; PROTEIN INTERACTION MAPPING;

EQUINE INFECTIOUS ANEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINE LEUKEMIA VIRUS;

EID: 84855862412     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00174-11     Document Type: Article

References (61)

1. Abacioglu, Y. H., et al. 1994. Epitope mapping and topology of baculovirusexpressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res. Hum. Retroviruses 10:371-381.
2. Accola, M. A., B. Strack, and H. G. Göttlinger. 2000. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J. Virol. 74:5395-5402.
3. Adachi, A., et al. 1986. Production of acquired immunodeficiency syndromeassociated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
4. Ash, S. C., D. Q. Yang, and D. E. Britt. 2008. LYRIC/AEG-1 overexpression modulates BCCIPalpha protein levels in prostate tumor cells. Biochem. Biophys. Res. Commun. 371:333-338.
5. Bieniasz, P. D. 2009. The cell biology of HIV virion genesis. Cell Host Microbe 5:550-558.
6. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
7. Bushman, F. D., et al. 2009. Host cell factors in HIV replication: metaanalysis of genome-wide studies. PLoS Pathog. 5:e1000437.
8. Campos-Olivas, R., J. L. Newman, and M. F. Summers. 2000. Solution structure and dynamics of the Rous sarcoma virus capsid protein and comparison with capsid proteins of other retroviruses. J. Mol. Biol. 296:633-649.
9. Carlson, L. A., et al. 2008. Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis. Cell Host Microbe 4:592-599.
10. Catrein, I., R. Herrmann, A. Bosserhoff, and T. Ruppert. 2005. Experimental proof for a signal peptidase I like activity in Mycoplasma pneumoniae, but absence of a gene encoding a conserved bacterial type I SPase. FEBS J. 272:2892-2900.
11. Châtel-Chaix, L., K. Boulay, A. J. Mouland, and L. DesGroseillers. 2008. The host protein Staufen1 interacts with the Pr55Gag zinc fingers and regulates HIV-1 assembly via its N-terminus. Retrovirology 5:41.
12. Châtel-Chaix, L., et al. 2004. Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles. Mol. Cell. Biol. 24:2637-2648.
13. Cimarelli, A., S. Sandin, S. Höglund, and J. Luban. 2000. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA. J. Virol. 74:3046-3057.
14. Cox, J., and M. Mann. 2008. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26:1367-1372.
15. Dettenhofer, M., and X. F. Yu. 1999. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J. Virol. 73:1460-1467.
16. Dou, J., et al. 2009. Characterization of a myristoylated, monomeric HIV Gag protein. Virology 387:341-352.
17. Emdad, L., et al. 2009. Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 106: 21300-21305.
18. Emdad, L., et al. 2006. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res. 66:1509-1516.
19. Franke, E. K., H. E. Yuan, and J. Luban. 1994. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372:359-362.
20. Freed, E. O. 2001. HIV-1 replication. Somat. Cell Mol. Genet. 26:13-33.
21. Freed, E. O., J. M. Orenstein, A. J. Buckler-White, and M. A. Martin. 1994. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68:5311-5320.
22. Ganser-Pornillos, B. K., M. Yeager, and W. I. Sundquist. 2008. The structural biology of HIV assembly. Curr. Opin. Struct. Biol. 18:203-217.
23. Gingras, A. C., et al. 2005. A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity. Mol. Cell. Proteomics 4:1725-1740.
24. Harada, S., Y. Koyanagi, and N. Yamamoto. 1985. Infection of HTLV-III/ LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229:563-566.
25. Hermida-Matsumoto, L., and M. D. Resh. 2000. Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J. Virol. 74:8670-8679.
26. Jäger, S., E. Gottwein, and H. G. Kräusslich. 2007. Ubiquitination of human immunodeficiency virus type 1 Gag is highly dependent on Gag membrane association. J. Virol. 81:9193-9201.
27. Kang, D. C., et al. 2005. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 353:8-15.
28. Kikuno, N., et al. 2007. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 26:7647-7655.
29. Konvalinka, J., et al. 1995. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity. J. Virol. 69:7180-7186.
30. Lange, S., M. Sylvester, M. Schümann, C. Freund, and E. Krause. 2010. Identification of phosphorylation-dependent interaction partners of the adapter protein ADAP using quantitative mass spectrometry: SILAC vs (18)O-labeling. J. Proteome Res. 9:4113-4122.
31. Lee, S. G., Z. Z. Su, L. Emdad, D. Sarkar, and P. B. Fisher. 2006. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc. Natl. Acad. Sci. U. S. A. 103:17390-17395.
32. Lee, S. G., et al. 2008. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 27:1114-1121.
33. Lingappa, J. R., J. E. Dooher, M. A. Newman, P. K. Kiser, and K. C. Klein. 2006. Basic residues in the nucleocapsid domain of Gag are required for interaction of HIV-1 gag with ABCE1 (HP68), a cellular protein important for HIV-1 capsid assembly. J. Biol. Chem. 281:3773-3784.
34. Luban, J., K. L. Bossolt, E. K. Franke, G. V. Kalpana, and S. P. Goff. 1993. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73:1067-1078.
35. Mouland, A. J., et al. 2000. The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation. J. Virol. 74:5441-5451.
36. Müller, B., et al. 2004. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J. Virol. 78:10803-10813.
37. Ong, S. E., et al. 2002. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1:376-386.
38. Ono, T., et al. 2000. TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase. J. Biol. Chem. 275:31145-31154.
39. Ott, D. E., et al. 1996. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J. Virol. 70:7734-7743.
40. Poon, D. T., J. Wu, and A. Aldovini. 1996. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity. J. Virol. 70:6607-6616.
41. Ptak, R. G., et al. 2008. Cataloguing the HIV type 1 human protein interaction network. AIDS Res. Hum. Retroviruses 24:1497-1502.
42. Rein, A. 2010. Nucleic acid chaperone activity of retroviral Gag proteins. RNA Biol. 7:61-66.
43. Rigaut, G., et al. 1999. A generic protein purification method for protein complex characterization and proteome exploration. Nat. Biotechnol. 17: 1030-1032.
44. Rothbauer, U., et al. 2008. A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins. Mol. Cell. Proteomics 7:282-289.
45. Roy, B. B., et al. 2006. Association of RNA helicase a with human immunodeficiency virus type 1 particles. J. Biol. Chem. 281:12625-12635.
46. Sarkar, D., et al. 2009. Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes. Cancer Res. 69:8529-8535.
47. Sarkar, D., et al. 2008. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res. 68:1478-1484.
48. Schneider, R., M. Campbell, G. Nasioulas, B. K. Felber, and G. N. Pavlakis. 1997. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J. Virol. 71:4892-4903.
49. Sherer, N. M., et al. 2003. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 4:785-801.
50. Strebel, K., et al. 1987. The HIV 'A' (sor) gene product is essential for virus infectivity. Nature 328:728-730.
51. Stremlau, M., et al. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848-853.
52. Tanzi, G. O., A. J. Piefer, and P. Bates. 2003. Equine infectious anemia virus utilizes host vesicular protein sorting machinery during particle release. J. Virol. 77:8440-8447.
53. Thali, M., et al. 1994. Functional association of cyclophilin A with HIV-1 virions. Nature 372:363-365.
54. Thirkettle, H. J., et al. 2009. LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals. Clin. Cancer Res. 15:3003-3013.
55. Trinkle-Mulcahy, L., et al. 2008. Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes. J. Cell Biol. 183:223-239.
56. Turner, B. G., and M. F. Summers. 1999. Structural biology of HIV. J. Mol. Biol. 285:1-32.
57. Vermeulen, M., N. C. Hubner, and M. Mann. 2008. High confidence determination of specific protein-protein interactions using quantitative mass spectrometry. Curr. Opin. Biotechnol. 19:331-337.
58. Weijtens, M. E., R. A. Willemsen, E. H. Hart, and R. L. Bolhuis. 1998. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes. Gene Ther. 5:1195-1203.
59. Welker, R., H. Hohenberg, U. Tessmer, C. Huckhagel, and H. G. Kräusslich. 2000. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J. Virol. 74:1168-1177.
60. Yoo, B. K., et al. 2009. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J. Clin. Invest. 119:465-477.
61. Zimmerman, C., et al. 2002. Identification of a host protein essential for assembly of immature HIV-1 capsids. Nature 415:88-92.